New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2013
10:11 EDTABAX, BP, PLCE, DVAX, TGP, CBSH, ALU, OC, TEVA, HNZ, DEPO, PETM, ARO, ASNA, BRY, ENDP, GLF, NBL, NVE, SM, TDW, WPZOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abaxis (ABAX) downgraded to Underperform from Neutral at BofA/Merrill... Aeropostale (ARO) downgraded to Hold from Buy at KeyBanc... Affymax (AFFY) downgraded to Neutral from Outperform at RW Baird... Ascena Retail (ASNA) downgraded to Hold from Buy at KeyBanc... Berry Petroleum (BRY) downgraded to Neutral from Positive at Susquehanna... Endo Health (ENDP) downgraded to Underweight from Neutral at Piper Jaffray... GulfMark Offshore (GLF) downgraded to Buy from Strong Buy at ISI Group... NV Energy (NVE) downgraded to Hold from Buy at Wunderlich... Noble Energy (NBL) downgraded to Buy from Conviction Buy at Goldman... SM Energy (SM) downgraded to Market Perform from Outperform at BMO Capital... Tidewater (TDW) downgraded to Neutral from Buy at ISI Group... PetSmart (PETM) downgraded to Equal Weight from Overweight at Johnson Rice... Depomed (DEPO) downgraded to Hold from Buy at WallachBeth... BP (BP) downgraded to Buy from Strong Buy at ISI Group... Children's Place (PLCE) downgraded at Janney Capital... Dynavax (DVAX) downgraded to Hold from Buy at MLV Equity... Teekay LNG (TGP) downgraded at Raymond James... Commerce Bancshares (CBSH) downgraded at Raymond James... Alcatel-Lucent (ALU) downgraded to Underweight from Neutral at HSBC... Teva (TEVA) downgraded to Hold from Buy at Argus... Owens Corning (OC) downgraded to Market Perform from Outperform at Wells Fargo... Heinz (HNZ) downgraded to Neutral from Buy at Citigroup... Williams Partners (WPZ) downgraded to Accumulate from Buy at Global Hunter.
News For ABAX;ARO;ASNA;BRY;ENDP;GLF;NBL;NVE;SM;TDW;PETM;DEPO;BP;PLCE;DVAX;TGP;CBSH;ALU;OC;TEVA;HNZ;WPZ From The Last 14 Days
Check below for free stories on ABAX;ARO;ASNA;BRY;ENDP;GLF;NBL;NVE;SM;TDW;PETM;DEPO;BP;PLCE;DVAX;TGP;CBSH;ALU;OC;TEVA;HNZ;WPZ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 17, 2014
17:03 EDTSMSM Energy: Mercy to withdraw resolution on Climate Change Mitigation Plan
Subscribe for More Information
08:38 EDTTEVATeva settles patent ligitigation with Pfizer on Celebrex
Teva (TEVA) announced that its subsidiary Teva Pharmaceuticals USA, Inc. has entered into a settlement with Pfizer (PFE) related to Teva’s generic version of Celebrex 50, 100, 200 and 400 mg capsules in the United States. Under the terms of the settlement, Teva may launch its generic versions in December 2014 or earlier under certain circumstances. Teva has received tentative approval from the U.S. Food and Drug Administration for all strengths and believes that it is first-to-file on at least the 100, 200 and 400 mg capsules. Sales of Celebrex were $2.2B in the U.S. according to IMS data as of December, 2013.
April 16, 2014
19:03 EDTSMEndeavour settles litigation with SM Energy
Endeavour (END) has reached a settlement with SM Energy (SM) regarding litigation filed against Endeavour in December 2011. Endeavour will pay SM Energy $5M and issue a note for $4.5M. The note will be paid in three graduated payments beginning in twelve months. Endeavour has also agreed to issue warrants valued at $3.75M (approximately 2.13M shares with a strike price of $5.29.) The total settlement expense to be recorded will be $19.25M, which includes deposits of $6M paid prior to the execution of the agreements.
13:22 EDTNBLNoble Energy bids to supply gas to Cypriot power station, Globes says
Subscribe for More Information
10:27 EDTENDPEndo International says AMS unit received FDA warning letter
In a regulatory filing, Endo International disclosed that as previously reported in Endo Health Solutions's Form 10-K filed with the SEC on March 3, in February 2014, the United States FDA conducted an inspection of the Minnetonka, Minnesota facility of American Medical Systems, AMS, a subsidiary of Endo International. Following such inspection, the FDA issued three observations on a Form 483 Notice of Inspectional Observations dated February 24. These observations, previously self-identified by AMS, were being addressed through a corrective action plan which AMS originally expected to complete beyond 2015. On April 14, AMS received a Warning Letter from the FDA, dated April 10. The Warning Letter relates to the same matters as identified in the Form 483 Notice. Specifically, the Warning Letter discusses observations related to process validation, risk analysis and corrective and preventive action procedures. The letter states that the corrective actions which AMS reviewed with the FDA on March 20, 2014 appear to be adequate, but it goes on to state that many of the actions have not yet been completed and will need to be validated in a follow-up inspection. AMS has 15 days to respond to the Warning Letter. AMS expects only limited related impact to its business at this time. The Minnetonka, Minnesota facility will continue to manufacture and ship products while AMS works with the FDA.
10:00 EDTTEVA, ENDPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: A10 Networks (ATEN) initiated with a Buy at BofA/Merrill... Actavis (ACT) initiated with a Buy at Sterne Agee... Allergan (AGN) initiated with a Buy at Sterne Agee... Autohome (ATHM) initiated with a Neutral at Credit Suisse... BitAuto (BITA) initiated with an Outperform at Credit Suisse... Centene (CNC) initiated with a Neutral at UBS... Endo International (ENDP) initiated with a Buy at Sterne Agee... FS Investment (FSIC) initiated with an Overweight at Evercore... Hertz (HTZ) initiated with a Buy at Gabelli... Hilton (HLT) initiated with a Hold at Jefferies... Hospira (HSP) initiated with a Neutral at Sterne Agee... ImmunoGen (IMGN) initiated with a Buy at Canaccord... Impax (IPXL) initiated with a Neutral at Sterne Agee... Imperva (IMPV) assumed with a Neutral at Wedbush... Ingredion (INGR) initiated with an Outperform at Credit Suisse... Laredo Petroleum (LPI) initiated with an Outperform at RW Baird... Lpath (LPTN) initiated with a Buy at Canaccord... MediWound (MDWD) initiated with an Outperform at Oppenheimer... Medivation (MDVN) initiated with a Hold at Canaccord... NPS Pharmaceuticals (NPSP) assumed with a Buy at Canaccord... Nimble Storage (NMBL) initiated with a Market Perform at Raymond James... Regeneron (REGN) initiated with a Buy at Canaccord... Salix (SLXP) initiated with a Buy at Sterne Agee... Sibanye Gold (SBGL) initiated with an Outperform at Imperial Capital... Teva (TEVA) initiated with a Neutral at Sterne Agee... Wipro (WIT) assumed with a Hold at Jefferies.
07:03 EDTENDPEndo International initiated with a Buy at Sterne Agee
Subscribe for More Information
07:00 EDTTEVATeva initiated with a Neutral at Sterne Agee
Subscribe for More Information
April 15, 2014
12:26 EDTTEVATeva announces launch of generic Lunesta tablets in U.S.
Subscribe for More Information
10:00 EDTPETMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:17 EDTNBLNoble Energy announces CEO Charles Davidson plans to retire
Subscribe for More Information
06:18 EDTPETMPetSmart downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill downgraded PetSmart to Underperform as it believes super premium natural pet food may be entering the mass market. The firm lowered its price target for shares to $60 from $77.
06:08 EDTDVAXDynavax initiates Phase 3 study of HEPLISAV-B
Dynavax Technologies announced initiation of a new phase 3 clinical trial of HEPLISAV-B, its investigational adult hepatitis B vaccine. This large safety and immunogenicity study, known as HBV-23, was designed to address the Complete Response Letter regarding the HEPLISAV-B Biologics License Application that was issued to Dynavax by the FDA in February, 2013. HBV-23 will provide greater clarity regarding the safety profile of HEPLISAV-B by significantly expanding the overall database of vaccinated subjects. The study will also assess the immunogenicity of HEPLISAV-B in subjects for whom approved hepatitis B vaccines are less effective. Dynavax expects that all study subjects will be enrolled by the end of 2014 and all follow-up will be completed by 4Q15.
April 14, 2014
10:02 EDTBPOn The Fly: Analyst Upgrade Summary
Acorda Therapeutics (ACOR) upgraded to Outperform from Market Perform at FBR Capital... Allegheny Technologies (ATI) upgraded to Neutral from Underperform at Sterne Agee... BP (BP) upgraded to Buy from Hold at Canaccord... Bloomin' Brands (BLMN) upgraded to Buy from Hold at Deutsche Bank... Boardwalk Pipeline (BWP) upgraded to Neutral from Underperform at BofA/Merrill... Boston Scientific (BSX) upgraded at BofA/Merrill... Charles Schwab (SCHW) upgraded to Buy from Neutral at UBS... Citigroup (C) upgraded to Hold from Sell at Rafferty Capital... Community Health (CYH) upgraded to Outperform from Perform at Oppenheimer... Eaton Vance (EV) upgraded to Neutral from Sell at Citigroup... Eli Lilly (LLY) upgraded to Hold from Underperform at Jefferies... F5 Networks (FFIV) upgraded to Buy from Hold at Stifel... HeartWare (HTWR) upgraded to Buy from Neutral at BTIG... Heartland Payment (HPY) upgraded to Hold from Sell at Stifel... Hyatt Hotels (H) upgraded to Outperform from Market Perform at FBR Capital... MasterCard (MA) upgraded to Outperform from Neutral at RW Baird... McDermott (MDR) upgraded to Neutral from Underweight at HSBC... Palo Alto (PANW) upgraded to Overweight at Stephens... PetroChina (PTR) upgraded to Neutral from Underperform at Credit Suisse... Seagate (STX) upgraded to Buy from Hold at Argus... Sensata (ST) upgraded to Buy from Neutral at Citigroup... Stryker (SYK) upgraded to Neutral from Reduce at SunTrust... TD Ameritrade (AMTD) upgraded to Buy from Neutral at UBS... TTM Technologies (TTMI) upgraded to Buy from Hold at Stifel... Transocean (RIG) upgraded to Hold from Sell at Deutsche Bank... VMware (VMW) upgraded to Outperform from Underperform at CLSA... Visa (V) upgraded to Outperform from Neutral at RW Baird... Yahoo (YHOO) upgraded to Buy from Neutral at SunTrust... Zimmer (ZMH) upgraded to Neutral from Reduce at SunTrust... bebe stores (BEBE) upgraded to Buy from Neutral at Janney Capital.
08:07 EDTDEPODepomed enters into settlement agreement with two Gralise's ANDA filers
Subscribe for More Information
05:54 EDTBPBP upgraded to Buy from Hold at Canaccord
Subscribe for More Information
April 11, 2014
09:05 EDTPLCEChildren's Place turnaround opportunities compelling, says FBR Capital
FBR Capital believes Children's Place offers one of the most compelling turnaround opportunities in specialty retail. FBR says it is more positive on the company's turnaround story after meeting with management and it reiterates an Outperform rating on the name with a $60 price target.
09:04 EDTAROAeropostale price target lowered to $5 from $7.50 at BofA/Merrill
Subscribe for More Information
08:11 EDTBPBP says can help improve relations between west, Russia, Reuters says
In an effort to calm shareholders' worries over the company's large exposure to Russia, BP executives said it can help improve relations between Russia and the west and is talking to politicians all over the globe, according to Reuters, citing comments from CEO Bob Dudley. Reference Link
April 10, 2014
07:06 EDTCBSHCommerce Bancshares reports Q1 EPS 67c, consensus 68c
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use